Evaluating Microarray Pharmacogenetic Testing in Cancer Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients — Stella

Recruiting

Back to Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Atrium Health Levine Cancer, Charlotte, North Carolina

Key details

Sponsor

Wake Forest University Health Sciences

Collaborators

Atrium Health Levine Cancer Institute

Enrollment target

~120 participants

Started

July 2025

Primary completion

December 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov